Trial
NCT03260868
Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Type 1 Diabetes Mellitus
Intervention
Insulin glargine, 300 units per milliliter (U/mL)
Why stopped
Due to "prolonged low participant recruitment"
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-07